Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125558141 | 12555814 | 1 | I | 20160629 | 20160714 | 20160714 | EXP | CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-120166 | RANBAXY | 65.00 | YR | M | Y | 0.00000 | 20160714 | OT | GB | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125558141 | 12555814 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Unknown | 500 MG, BID | Y | 65382 | 500 | MG | Q12H | ||||||
| 125558141 | 12555814 | 2 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Y | 65382 | |||||||||||
| 125558141 | 12555814 | 3 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Y | 65382 | |||||||||||
| 125558141 | 12555814 | 4 | I | Rivaroxaban | RIVAROXABAN | 1 | Unknown | 20 MG, DAILY | Y | 0 | 20 | MG | |||||||
| 125558141 | 12555814 | 5 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | DOUBLE-STRENGTH | U | 0 | TABLET | ||||||||
| 125558141 | 12555814 | 6 | C | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 650 MG, 3 MONTHLY | U | 0 | 650 | MG | |||||||
| 125558141 | 12555814 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 5 MG, DAILY | U | 0 | 5 | MG | |||||||
| 125558141 | 12555814 | 8 | C | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, DAILY | U | 0 | 40 | MG | |||||||
| 125558141 | 12555814 | 9 | C | Tiotropium | TIOTROPIUM | 1 | Unknown | 18 ?G, DAILY | U | 0 | 18 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125558141 | 12555814 | 1 | Oropharyngeal pain |
| 125558141 | 12555814 | 2 | Dyspnoea |
| 125558141 | 12555814 | 3 | Cough |
| 125558141 | 12555814 | 4 | Product used for unknown indication |
| 125558141 | 12555814 | 5 | Antifungal prophylaxis |
| 125558141 | 12555814 | 6 | Product used for unknown indication |
| 125558141 | 12555814 | 7 | Product used for unknown indication |
| 125558141 | 12555814 | 8 | Product used for unknown indication |
| 125558141 | 12555814 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125558141 | 12555814 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125558141 | 12555814 | Drug interaction | |
| 125558141 | 12555814 | Epistaxis | |
| 125558141 | 12555814 | Haemoptysis | |
| 125558141 | 12555814 | Haemorrhage intracranial | |
| 125558141 | 12555814 | Headache | |
| 125558141 | 12555814 | Pulmonary haemorrhage | |
| 125558141 | 12555814 | Self-medication | |
| 125558141 | 12555814 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |